The company's proprietary recombinant technology platform harnesses the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles designed to address urgent global health needs.
Mashruuca tiknoolajiyadda dib -u -warshadaynta lahaanshaha ee shirkaddu wuxuu isku daraa awoodda iyo xawaaraha injineernimada hidda -wadaha si uu si hufan u soo saaro nanoparticles immunogenic oo heer sare ah oo loogu talagalay inuu wax ka qabto baahiyaha caafimaad ee caalamiga ah ee degdegga ah.